Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 378.00
-24.00 (-5.97%)
Oct 23, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 113.52 million as of October 23, 2026. It is the 31,983rd most valuable company in the world and the 368th biggest in Israel. Its market cap has decreased by 46.80% in one year.
Market Cap
113.52M
Enterprise Value
105.43M
Revenue
2.32M
Global Rank
Country Rank
#368 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 113.52M, a decrease of -90.58%. That is a compound annual growth rate of -38.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 113.52M | -37.70% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.67B |
| Amal Holdings A.D. | 2.16B |
| Rafa Laboratories | 1.77B |
| BrainsWay | 1.48B |
| Bonus BioGroup | 209.10M |
| InterCure | 171.53M |
| Golden House | 156.25M |
| Rekah Pharmaceutical Industry | 119.17M |